HCPCS Code Descriptor:
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
Route of Administration:
TRUXIMA is an Oncology Biosimilar drug manufactured by Cephalon and administered via the Intravenous route of administration. The Q Code: Q5115 is aligned to the drug TRUXIMA.
Truxima is used to treat certain types of cancer, joint pain, certain blood vessel diseases, and a certain skin condition. Truxima works by slowing down or stopping the growth of certain cells, which can be cancer-causing. Truxima is a branded drug manufactured by Cephalon and is a biosimilar to the reference product Rituxan (J9312). Patient assistance programs for this medication can be found through Teva pharmaceuticals.